We used the following keywords: GLP-1, GLP-1 receptor agonist, exenatide, liraglutide, lixisenatide, semaglutide, albiglutide, dulaglutide, efpeglenatide, coronary artery disease, coronary atherosclerosis, endothelial dysfunction, inflammation, body weight, blood pressure, lipids, aggregation, coagulation, coronary vasospasm, coronary vasodilation, coronary microvascular, acute coronary syndrome, myocardial infarction, unstable angina, stable angina, chronic coronary syndrome, vasospastic angina, microvascular angina, coronary revascularization
& Ke, L
Patients with pre-existing gastric motility disorders or a personal history of gastroparesis do carry higher risk and should discuss GLP-1 candidacy with their physician before starting treatment
However, there is no solid data validating any association, and this article does not describe any protocol
These medications prompt the pancreas to release more insulin when blood sugar levels are high, helping regulate blood glucose